Mylan (MYL -1.4%) says its being sued by Endo Pharmaceuticals (ENDP -1.59%) over its application...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL -1.4%) says its being sued by Endo Pharmaceuticals (ENDP -1.59%) over its application for approval of frovatriptan succinate EQ, a generic version of Endo's Frova. Both drugs are used to treat acute migraine headaches in adults.